In addition, other neurotransmitter systems are also affected in AD, and there is growing evidence that pathological changes in AD, such as Aβ plaques and Tau neurofibrillary tangles, can lead to synaptic dysfunction and neuronal loss. The gene discussed is MAPT; the disease is Alzheimer disease.